A study published online today (May 26, 2012) in Current Psychiatry Reports recommends Zyprexa as “elusive” pharmacologic solution to anorexia nervosa. On the basis of four randomized clinical trials, the study finds Zyprexa superior to placebo, Thorazine and Abilify in its ability to promote “weight gain and/or reduction in obsessional symptoms.”
Brewerton, T. “Antipsychotic Agents in the Treatment of Anorexia Nervosa: Neuropsychopharmacologic Rationale and Evidence from Controlled Trials.” Current Psychiatry Reports, published online May 26, 2012
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.